Been buying this beauty since it was $1.25 and intend to hold until the fall. By then, analysts expect it to be $25-30/share.
This is a Paul Schimmel (Billionaire Biotech Chemist) company and they’ve got a miracle drug to treat lung inflammation, which hasn’t seen anything new in 60 years. But instead of using steroids, which have horrible long-term side effects, ATYR’s drug heals with none.
This is a $5B opportunity and ATYR has no competition. Closest competitor is 5 years behind. This stock is a 10 banger if I’ve ever seen one. I’m all in!